The cardiovascular system connects all tissues and organs in the body. Metabolic equivalence and regulation play crucial roles in maintaining cardiovascular health and promoting healthy aging and public health. However, cardiometabolic dysregulation or diseases, such as hypertension, coronary heart disease, heart failure, diabetes, and lipid dysregulation, impose significant barriers to healthy aging in older adults. It is projected that the global population aged 60 years and above will increase from 12% to 22% between 2015 and 2050. This surge in older adults will not only impact the healthcare system, but also place burdens on families. Given the key role of the cardiometabolic system in health maintenance, it is essential to investigate comprehensive evaluation, prevention, and management strategies for cardiometabolic dysregulation and diseases in older adults, in order to promote healthy aging.This research topic aims to investigate the associations between cardiometabolic risk and protective factor, dysregulations, chronic diseases, and healthy aging, particularly in older adults. The objective is to provide evidence on how to comprehensively evaluate, prevent and manage cardiometabolic dysregulation and diseases in older adults. The studies on the early evaluation of cardiometabolic dysfunction or the prevention of relevant diseases from middle age to old age are also welcomed. It is our hope that this research topic will contribute recommendations for future research and policy interventions concerning cardiometabolic dysregulation and diseases in healthy aging.This Research Topic particularly encourages submissions based on large-scale or large-sample surveys or cohorts and look forward to receiving high-quality contributions to advance our understanding of cardiometabolic dysregulation and diseases in healthy aging. And the submissions featured on this research topic need to be relevant to public health and aging. It is essential that each submission describe the problem in public health terms, and also provide implications for public health. However, articles solely focused on physiological or clinical aspects will not be considered. Original research, review articles, case studies, clinical trials, systematic reviews, and meta-analyses are expected to include but not limited to the following topics:• Epidemiological research on cardiometabolic dysregulation or diseases in older adults.• Measures, phenotypes, or indices used to define or evaluate cardiometabolic dysregulation or diseases in middle-aged and older adults.• Identification of risk and protective factors for cardiometabolic dysregulation or diseases in older adults.• Pharmacological and non-pharmacological modalities for the prevention of cardiometabolic dysregulation or diseases in middle-aged and older adults.• Management of cardiometabolic dysregulation or diseases in older adults, in hospital settings or in communities.Note: Please note that this section adheres to The Gerontological Society of America Reframing Aging Journal Manuscript Guidelines advice against ageist language. For example, the guidelines emphasize to support a more inclusive image of aging. Terms such as “older adult,” “older persons,” or “older people” are the preferred terms for describing individuals aged 65 years and older as opposed to “seniors,” “the elderly,” and “the aged.” Use of this recommended language will be a criteria for acceptance and you can view an example of these guidelines here. Additionally, please refer to APA guidelines (Equity, Diversity, and Inclusion INCLUSIVE LANGUAGE GUIDELINES) for more guidance about inclusionary language.
The cardiovascular system connects all tissues and organs in the body. Metabolic equivalence and regulation play crucial roles in maintaining cardiovascular health and promoting healthy aging and public health. However, cardiometabolic dysregulation or diseases, such as hypertension, coronary heart disease, heart failure, diabetes, and lipid dysregulation, impose significant barriers to healthy aging in older adults. It is projected that the global population aged 60 years and above will increase from 12% to 22% between 2015 and 2050. This surge in older adults will not only impact the healthcare system, but also place burdens on families. Given the key role of the cardiometabolic system in health maintenance, it is essential to investigate comprehensive evaluation, prevention, and management strategies for cardiometabolic dysregulation and diseases in older adults, in order to promote healthy aging.This research topic aims to investigate the associations between cardiometabolic risk and protective factor, dysregulations, chronic diseases, and healthy aging, particularly in older adults. The objective is to provide evidence on how to comprehensively evaluate, prevent and manage cardiometabolic dysregulation and diseases in older adults. The studies on the early evaluation of cardiometabolic dysfunction or the prevention of relevant diseases from middle age to old age are also welcomed. It is our hope that this research topic will contribute recommendations for future research and policy interventions concerning cardiometabolic dysregulation and diseases in healthy aging.This Research Topic particularly encourages submissions based on large-scale or large-sample surveys or cohorts and look forward to receiving high-quality contributions to advance our understanding of cardiometabolic dysregulation and diseases in healthy aging. And the submissions featured on this research topic need to be relevant to public health and aging. It is essential that each submission describe the problem in public health terms, and also provide implications for public health. However, articles solely focused on physiological or clinical aspects will not be considered. Original research, review articles, case studies, clinical trials, systematic reviews, and meta-analyses are expected to include but not limited to the following topics:• Epidemiological research on cardiometabolic dysregulation or diseases in older adults.• Measures, phenotypes, or indices used to define or evaluate cardiometabolic dysregulation or diseases in middle-aged and older adults.• Identification of risk and protective factors for cardiometabolic dysregulation or diseases in older adults.• Pharmacological and non-pharmacological modalities for the prevention of cardiometabolic dysregulation or diseases in middle-aged and older adults.• Management of cardiometabolic dysregulation or diseases in older adults, in hospital settings or in communities.Note: Please note that this section adheres to The Gerontological Society of America Reframing Aging Journal Manuscript Guidelines advice against ageist language. For example, the guidelines emphasize to support a more inclusive image of aging. Terms such as “older adult,” “older persons,” or “older people” are the preferred terms for describing individuals aged 65 years and older as opposed to “seniors,” “the elderly,” and “the aged.” Use of this recommended language will be a criteria for acceptance and you can view an example of these guidelines here. Additionally, please refer to APA guidelines (Equity, Diversity, and Inclusion INCLUSIVE LANGUAGE GUIDELINES) for more guidance about inclusionary language.
